VOTRIENT (pazopanib) Patient Assistance Program
Don’t let the high cost of brand specialty oral oncology multi-kinase inhibitor therapy disrupt your treatment. We help eligible patients access Votrient (pazopanib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Votrient (pazopanib) is FDA-approved for advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma in patients who have received prior chemotherapy. It is an oral multi-kinase inhibitor targeting VEGFR, PDGFR, c-Kit, and FGFR.
- Without assistance, brand Votrient costs commonly run approximately $13,000–$15,500 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Votrient for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic pazopanib is now available in the U.S. at substantially lower cost. For advanced RCC, other treatment options include sunitinib (Sutent, generic), cabozantinib (Cabometyx), axitinib (Inlyta), and combinations with immunotherapy (Keytruda, Opdivo). For sarcoma, options include doxorubicin (generic), gemcitabine + docetaxel (generic), eribulin (Halaven), and trabectedin (Yondelis).
What Is Votrient Prescription Assistance Program?
The Votrient Prescription Assistance Program is a manufacturer-sponsored initiative that provides Votrient at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for advanced RCC and soft tissue sarcoma patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, oncology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, brand Votrient costs roughly $13,000–$15,500/month. Generic pazopanib is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$15,000 | Save ~$14,930/mo |
| CVS Pharmacy (brand) | ~$15,500 | Save ~$15,430/mo |
| Walmart (brand) | ~$13,500 | Save ~$13,430/mo |
| Costco (brand) | ~$13,200 | Save ~$13,130/mo |
Generic pazopanib | ~$3,000 | Generic low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Votrient Prescription Program?
The Patient Assistance Program is free to apply for and provides Votrient at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic pazopanib now available at lower cost, we’ll help you and your oncologist determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Votrient:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $13,000–$15,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Votrient assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Votrient Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Votrient:
Votrient (pazopanib) is a once-daily oral multi-kinase inhibitor used for advanced renal cell carcinoma and advanced soft tissue sarcoma. It blocks multiple tyrosine kinases that drive tumor angiogenesis and proliferation.
How Votrient Works:
Pazopanib is a medication that works by blocking multiple tyrosine kinases, including VEGFR, PDGFR, c-Kit, and FGFR. Cancers often rely on these specific signals to stimulate angiogenesis, which is the growth of new blood vessels needed to feed and expand tumors. By simultaneously halting these pathways, the drug effectively inhibits both blood vessel growth and direct tumor cell proliferation. This combined action ultimately results in tumor shrinkage and prolongs progression-free survival for patients.
Form and use:
This medication is supplied under the brand name Votrient and is taken orally once daily at a standard dose of 800 mg. It must strictly be taken on an empty stomach, meaning either at least 1 hour before a meal or 2 hours after one. Adhering to the empty-stomach rule is critical because consuming food significantly increases the absorption of the drug. Additionally, patients must ingest the tablets whole without crushing, chewing, or splitting them.
Generic availability:
Generic versions of pazopanib are currently available in the United States, offering a substantially lower cost compared to the brand-name drug Votrient. For advanced renal cell carcinoma (RCC), patients have alternative options such as sunitinib, cabozantinib, axitinib, tivozanib, or various immunotherapy combinations. If being treated for soft tissue sarcoma, alternative therapeutic options include doxorubicin, gemcitabine plus docetaxel, eribulin, and trabectedin.
Warnings:
Votrient carries a serious Boxed Warning for severe and potentially fatal hepatotoxicity, requiring regular liver function tests before and during treatment. The medication is also associated with cardiovascular risks, including QT prolongation, heart failure from LVEF decline, severe hypertension, and thromboembolic or hemorrhagic events. Furthermore, patients face potential risks of gastrointestinal perforations, wound healing complications, lung disease, and embryo-fetal toxicity. Blood pressure and electrolytes must be actively monitored and managed to mitigate these serious adverse effects.
FAQ (Frequently Asked Questions)
How Much Does Votrient Cost Without Insurance?
Brand Votrient costs approximately $13,000–$15,500 per 30-day supply. Generic pazopanib is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Votrient at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Take Votrient On An Empty Stomach?
Food significantly increases pazopanib absorption — taking Votrient with food can roughly double drug levels, increasing toxicity risk including liver injury and QT prolongation. Take Votrient at least 1 hour before or 2 hours after a meal. Avoid grapefruit and grapefruit juice (which also raise pazopanib levels).
How Is Votrient Different From Other RCC Therapies?
Votrient (pazopanib), sunitinib (Sutent), cabozantinib (Cabometyx), and axitinib (Inlyta) are all VEGFR-targeted multi-kinase inhibitors for advanced RCC. They have differing kinase profiles and side-effect patterns. Modern first-line RCC therapy often uses immunotherapy combinations (Keytruda + axitinib, Lenvima + Keytruda, Opdivo + Yervoy) when feasible — multi-kinase inhibitor monotherapy is now more common in second-line or in patients who can’t tolerate immunotherapy.
Why Do I Need Liver Function Tests So Often?
Pazopanib can cause severe, sometimes fatal hepatotoxicity (the boxed warning). LFTs should be checked at baseline, every 2 weeks for the first 2 months, then monthly for at least 4 months. Significant LFT elevations may require dose interruption, reduction, or discontinuation. Tell your oncologist promptly about jaundice, severe fatigue, dark urine, light stools, or abdominal pain.
What About Blood Pressure And Votrient?
VEGFR-targeted therapies including Votrient commonly cause hypertension. Blood pressure should be measured at baseline and frequently during therapy. Antihypertensive treatment (ACE inhibitors, ARBs, calcium channel blockers, etc.) is often needed and is usually compatible with Votrient. Severe or uncontrolled hypertension may require dose adjustment of Votrient.
Are There Drug Interactions I Should Know About?Are There Drug Interactions I Should Know About?
Yes. Pazopanib is a CYP3A substrate and a CYP3A/2C8/2D6 inhibitor. Strong CYP3A inhibitors raise levels; strong CYP3A inducers lower levels. Acid-reducing drugs (PPIs, H2 blockers) can reduce pazopanib absorption — timing precautions needed. Other QT-prolonging drugs should be avoided where possible. Tell every prescriber and pharmacist about Votrient.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic pazopanib (much cheaper), or to another RCC or sarcoma therapy (generic sunitinib, generic axitinib, cabozantinib, immunotherapy combinations), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Kidney Cancer Association, Sarcoma Foundation of America, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Votrient, our team may be able to help you access assistance programs — or guide you to generic pazopanib if it fits your situation. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.